Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment reporting

Analytics

N/A

5(71.4%)

Phase 1/2

1(14.3%)

Phase 2

1(14.3%)

7Total

N/A(5)

Phase 1/2(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07207941Not ApplicableNot Yet Recruiting

Effect of Probiotics on Quality of Life, Activities of Daily Living and Anxiety in Post Stroke Patients

Role: collaborator

NCT07100743Not ApplicableActive Not Recruiting

Trial of Multi-Strain Probiotic Supplementation (Hexbio®) in Malaysian Patients With Drug-Resistant Epilepsy (ProbE)

Role: collaborator

NCT06925386Phase 2Not Yet Recruiting

The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment

Role: collaborator

NCT06890221Not ApplicableRecruiting

Impact of PErioperative Nutrition Intervention on Bioimpedance Phase Angle (IPENIPA) In Breast Cancer Patients

Role: collaborator

NCT05273073Not ApplicableCompleted

Effects of Probiotics on Gut Microbiota Composition and Metabolic Outcomes in Post- Gestational Diabetes Women

Role: collaborator

NCT04119011Phase 1/2Completed

Probiotics in Women With Primary Dysmenorrhoea

Role: collaborator

NCT04074889Not ApplicableUnknown

The Effect of Probiotics on the Clinical Outcomes and Gut Microenvironment in Patients With Fatty Liver

Role: collaborator

All 7 trials loaded